![](https://www.diabetesnews.com/wp-content/uploads/2012/04/clever-pills-150x150.jpg)
Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.
Read more
Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.
Read more